DIABETIC RETINOPATHY
Clinical trials for DIABETIC RETINOPATHY explained in plain language.
Never miss a new study
Get alerted when new DIABETIC RETINOPATHY trials appear
Sign up with your email to follow new studies for DIABETIC RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Parkinson's drug tested to stop diabetes from stealing sight
Disease control CompletedThis study tested whether levodopa, a medication used for Parkinson's disease, could help protect the eyes of people with diabetes before visible damage occurs. 230 participants, including veterans, took either a placebo or different doses of levodopa for six months. Researchers …
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 03, 2026 19:58 UTC
-
Fish oil pills tested to protect Diabetics' eyesight
Disease control CompletedThis study tested whether taking daily omega-3 supplements could help treat early-stage diabetic retinopathy, a common diabetes complication that can damage eyesight. Researchers gave 60 adults with mild to moderate diabetic eye disease either omega-3 pills or a placebo for six m…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Disease control
Last updated Apr 03, 2026 19:56 UTC
-
Eye injection tested to stop diabetic blindness before it starts
Disease control CompletedThis study tested whether a medication called aflibercept, injected into the eye, could improve poor blood flow in the retinas of people with diabetic retinopathy. Researchers enrolled 38 adults with moderate diabetic eye damage to see if the treatment could restore circulation a…
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Eye drop trial aims to halt diabetic vision damage
Disease control CompletedThis study tested whether a new eye drop called INV-102 could help control diabetic retinopathy, a common cause of vision loss. It involved 19 adults with diabetes who had swelling in the back of the eye. Researchers gave participants the eye drops for 8-12 weeks to see if it red…
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE2 • Sponsor: Invirsa, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New pill tested to fight Diabetes-Related vision loss
Disease control CompletedThis study tested an oral supplement called Nuvastatic to see if it could help control early-stage diabetic retinopathy, a common diabetes complication that damages the retina and can lead to vision loss. It involved 100 adults with type 2 diabetes who had this early eye disease …
Matched conditions: DIABETIC RETINOPATHY
Phase: PHASE1, PHASE2 • Sponsor: Natureceuticals Sdn Bhd • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
AI eye tracker could let patients monitor vision loss from home
Diagnosis CompletedThis study tested a new home device called CRYSTALSIGHT that uses a camera and artificial intelligence to track eye movements. The goal was to see if it could reliably monitor diseases like macular degeneration and diabetic retinopathy remotely, potentially reducing the need for …
Matched conditions: DIABETIC RETINOPATHY
Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC
-
New AI tool aims to catch diabetic eye disease early
Diagnosis CompletedThis study tested a new automated tool designed to screen for diabetic retinopathy, a serious eye complication of diabetes. The goal was to see if this tool could work well in primary care clinics, making screening easier and more accessible for people with diabetes. Researchers …
Matched conditions: DIABETIC RETINOPATHY
Sponsor: Optain Health • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
AI steps in to predict diabetic blindness risk
Diagnosis CompletedThis study aimed to develop and test an artificial intelligence (AI) system to better predict the worsening of diabetic retinopathy, a common diabetes complication that can lead to vision loss. Researchers followed over 3,000 diabetic patients for up to three years, collecting ey…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
AI vs. doctors: the race to catch diabetic blindness
Diagnosis CompletedThis study tested whether a computer program using artificial intelligence (AI) could accurately detect diabetic eye disease from photos of the back of the eye. It involved 900 people with diabetes and compared the AI's ability to spot problems against the readings of family doct…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
Yale tests new program to stop diabetes patients from going blind
Prevention CompletedThis Yale University study tested a patient navigator program designed to help people with diabetes get regular eye exams to prevent blindness. The program focused on high-risk patients who hadn't had eye screenings in over a year. Researchers worked with 35 participants to see i…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Mar 23, 2026 15:17 UTC
-
Eye scans may hold key to personalizing treatment for diabetic vision loss
Knowledge-focused CompletedThis study aimed to find out if specific patterns seen on standard eye scans could predict how well a patient with diabetic macular edema (DME) would respond to treatment. Researchers observed 32 patients with DME, analyzing their routine eye imaging to see if certain scan featur…
Matched conditions: DIABETIC RETINOPATHY
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Apr 03, 2026 19:56 UTC
-
Scientists hunt for blood clues to predict diabetic blindness
Knowledge-focused CompletedThis study aimed to find out if certain substances in the blood are linked to the severity of diabetic eye damage. Researchers compared blood samples and detailed eye scans from 90 adults, including people with and without diabetes. The goal was to see if measuring these blood ma…
Matched conditions: DIABETIC RETINOPATHY
Phase: NA • Sponsor: Elazıg Fethi Sekin Sehir Hastanesi • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC